N-[(2S,3S)-1-[[5-(1,3-benzodioxol-5-yl)-1,3,4-thiadiazol-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-4-ethylbenzamide

C24H26N4O4S — CID 92517671

IUPACN-[(2S,3S)-1-[[5-(1,3-benzodioxol-5-yl)-1,3,4-thiadiazol-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-4-ethylbenzamide
SMILESCCc1ccc(C(=O)N[C@H](C(=O)Nc2nnc(-c3ccc4c(c3)OCO4)s2)[C@@H](C)CC)cc1
InChIInChI=1S/C24H26N4O4S/c1-4-14(3)20(25-21(29)16-8-6-15(5-2)7-9-16)22(30)26-24-28-27-23(33-24)17-10-11-18-19(12-17)32-13-31-18/h6-12,14,20H,4-5,13H2,1-3H3,(H,25,29)(H,26,28,30)/t14-,20-/m0/s1
InChIKeyWKENYYXSLOKTTR-XOBRGWDASA-N
MW466.56 g/mol
LogP4.28
Rot. Bonds8

About N-[(2S,3S)-1-[[5-(1,3-benzodioxol-5-yl)-1,3,4-thiadiazol-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-4-ethylbenzamide

N-[(2S,3S)-1-[[5-(1,3-benzodioxol-5-yl)-1,3,4-thiadiazol-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-4-ethylbenzamide (PubChem CID 92517671) has the molecular formula C24H26N4O4S and a molecular weight of 466.56 g/mol. Its IUPAC name is N-[(2S,3S)-1-[[5-(1,3-benzodioxol-5-yl)-1,3,4-thiadiazol-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-4-ethylbenzamide.

Molecular Properties

Compound NameN-[(2S,3S)-1-[[5-(1,3-benzodioxol-5-yl)-1,3,4-thiadiazol-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-4-ethylbenzamide
PubChem CID92517671
Molecular FormulaC24H26N4O4S
Molecular Weight466.56 g/mol
Exact Mass466.17
IUPAC NameN-[(2S,3S)-1-[[5-(1,3-benzodioxol-5-yl)-1,3,4-thiadiazol-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-4-ethylbenzamide
SMILESCCc1ccc(C(=O)N[C@H](C(=O)Nc2nnc(-c3ccc4c(c3)OCO4)s2)[C@@H](C)CC)cc1
InChIInChI=1S/C24H26N4O4S/c1-4-14(3)20(25-21(29)16-8-6-15(5-2)7-9-16)22(30)26-24-28-27-23(33-24)17-10-11-18-19(12-17)32-13-31-18/h6-12,14,20H,4-5,13H2,1-3H3,(H,25,29)(H,26,28,30)/t14-,20-/m0/s1
InChIKeyWKENYYXSLOKTTR-XOBRGWDASA-N
XLogP4.28
TPSA102.44 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds8
Heavy Atoms33
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500466.56
LogP ≤ 54.28
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Analyze N-[(2S,3S)-1-[[5-(1,3-benzodioxol-5-yl)-1,3,4-thiadiazol-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-4-ethylbenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(2S,3S)-1-[[5-(1,3-benzodioxol-5-yl)-1,3,4-thiadiazol-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-4-ethylbenzamide?
The IUPAC name of N-[(2S,3S)-1-[[5-(1,3-benzodioxol-5-yl)-1,3,4-thiadiazol-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-4-ethylbenzamide (CID 92517671) is N-[(2S,3S)-1-[[5-(1,3-benzodioxol-5-yl)-1,3,4-thiadiazol-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-4-ethylbenzamide.
What is the SMILES notation for N-[(2S,3S)-1-[[5-(1,3-benzodioxol-5-yl)-1,3,4-thiadiazol-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-4-ethylbenzamide?
The canonical SMILES for N-[(2S,3S)-1-[[5-(1,3-benzodioxol-5-yl)-1,3,4-thiadiazol-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-4-ethylbenzamide is CCc1ccc(C(=O)N[C@H](C(=O)Nc2nnc(-c3ccc4c(c3)OCO4)s2)[C@@H](C)CC)cc1.
What is the InChIKey of N-[(2S,3S)-1-[[5-(1,3-benzodioxol-5-yl)-1,3,4-thiadiazol-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-4-ethylbenzamide?
The InChIKey is WKENYYXSLOKTTR-XOBRGWDASA-N. The full InChI is InChI=1S/C24H26N4O4S/c1-4-14(3)20(25-21(29)16-8-6-15(5-2)7-9-16)22(30)26-24-28-27-23(33-24)17-10-11-18-19(12-17)32-13-31-18/h6-12,14,20H,4-5,13H2,1-3H3,(H,25,29)(H,26,28,30)/t14-,20-/m0/s1.
What are the key properties of N-[(2S,3S)-1-[[5-(1,3-benzodioxol-5-yl)-1,3,4-thiadiazol-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-4-ethylbenzamide?
N-[(2S,3S)-1-[[5-(1,3-benzodioxol-5-yl)-1,3,4-thiadiazol-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-4-ethylbenzamide has a molecular weight of 466.56 g/mol, XLogP of 4.28, 8 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(2S,3S)-1-[[5-(1,3-benzodioxol-5-yl)-1,3,4-thiadiazol-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-4-ethylbenzamide is sourced from PubChem (CID 92517671), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).